,outcome,arm 1,arm 2
0,intervention,CHF,CHF
0,Protocol-defined cardiotoxicity,2 cases,9 cases
0,"Protocol-defined cardiotoxicity, total study group","13 % of TLC D-99, 29 % of doxorubicin, CHF","13 % of TLC D-99, 29 % of doxorubicin, CHF"
